Jiangsu GDK Ownership

Jiangsu GDK Biotechnology has a total of 123.2 Million outstanding shares. Jiangsu GDK retains majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 77.29 (percent) of Jiangsu GDK outstanding shares that are owned by insiders attests that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it. Some institutional investors establish a significant position in stocks such as Jiangsu GDK in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Jiangsu GDK, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits. As of December 1, 2024, Dividends Paid is expected to decline to about 14.6 M. As of December 1, 2024, Common Stock Shares Outstanding is expected to decline to about 83 M. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Jiangsu GDK Biotechnology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.